Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 16

Results For "public"

1169 News Found

The Semaglutide Surge: How a diabetes therapy sparked India’s weight loss wave
Healthcare | April 07, 2026

The Semaglutide Surge: How a diabetes therapy sparked India’s weight loss wave

As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact


Dharmendra Singh Gangwar appointed CEO of Rajiv Gandhi Cancer Institute
People | April 06, 2026

Dharmendra Singh Gangwar appointed CEO of Rajiv Gandhi Cancer Institute

Former Interim CEO takes charge to drive strategic growth, strengthen clinical excellence, and advance patient-centric oncology innovation


Sanofi appoints Dr Parikshit Chaudhari as Head of Market Access & Pricing Strategy
People | April 06, 2026

Sanofi appoints Dr Parikshit Chaudhari as Head of Market Access & Pricing Strategy

He brings extensive cross-functional expertise built through leadership roles


CSIR-CFTRI strengthens food innovation ecosystem with BioNEST launch, 26 startups supported
Startup | April 05, 2026

CSIR-CFTRI strengthens food innovation ecosystem with BioNEST launch, 26 startups supported

Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation


Danone India sets record with 20,911 healthcare pledges to fight anemia
Healthcare | April 05, 2026

Danone India sets record with 20,911 healthcare pledges to fight anemia

The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign


Concept Medical unveils landmark SirPAD trial at ACC 2026, advancing PAD treatment
Medical Device | April 03, 2026

Concept Medical unveils landmark SirPAD trial at ACC 2026, advancing PAD treatment

The SirPAD trial marks a significant milestone in vascular intervention, positioning MagicTouch PTA as a promising future alternative for PAD treatment


Q2 2026 drug catalysts put Replimune, Arvinas and Boehringer in sharp focus: GlobalData
Biopharma | April 03, 2026

Q2 2026 drug catalysts put Replimune, Arvinas and Boehringer in sharp focus: GlobalData

Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning


Merck launches high-stakes trial of dual-action eye drug aiming to halt leading cause of blindness
Clinical Trials | April 03, 2026

Merck launches high-stakes trial of dual-action eye drug aiming to halt leading cause of blindness

The trial, dubbed MALBEC, marks the first in a broader late-phase development push for MK-8748, with a second NVAMD study expected to begin later this year